Stephens Reiterates Overweight Rating on Veeva Systems (VEEV) Following 3Q Earnings Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Forward Air (FWRD) Appoints Shawn Stewart as CEO
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Veeva Systems (VEEV) PT Raised to $176 at Barclays
November 27, 2019 4:31 AM ESTBarclays analyst Saket Kalia raised the price target on Veeva Systems (NYSE: VEEV) to $176.00 (from $165.00) while maintaining a Equalweight rating.... More
After-Hours Movers 11/26: (ONTX) (TNXP) (BOX) Higher; (ARAV) (ATHX) (GES) Lower (more...)
November 26, 2019 6:00 PM ESTAfter-Hours Movers
Onconova Therapeutic (NASDAQ: ONTX) 13.4% HIGHER; Steven Cohen's fund Point72 Asset Management, L.P. disclosed a 9.99%, or 3,230,434 share, stake in the company.
Aravive, Inc. (Nasdaq: ARAV) 13.3% LOWER; announced that it has commenced an underwritten public offering of the sale of its shares of common stock.
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.3% HIGHER; received the official minutes from the Breakthrough Therapy Type B Clinical... More
Veeva Systems (VEEV) Tops Q3 EPS by 6c, Offers Q4 Guidance
November 26, 2019 4:10 PM ESTVeeva Systems (NYSE: VEEV) reported Q3 EPS of $0.60, $0.06 better than the analyst estimate of $0.54. Revenue for the quarter came in at $280.9 million versus the consensus estimate of $274.78 million.
GUIDANCE:
Veeva Systems sees Q4 2020 EPS of $0.51-$0.52, versus the consensus of... More
